DE60222265D1 - Zelltod-induktoren für mastzellen - Google Patents

Zelltod-induktoren für mastzellen

Info

Publication number
DE60222265D1
DE60222265D1 DE60222265T DE60222265T DE60222265D1 DE 60222265 D1 DE60222265 D1 DE 60222265D1 DE 60222265 T DE60222265 T DE 60222265T DE 60222265 T DE60222265 T DE 60222265T DE 60222265 D1 DE60222265 D1 DE 60222265D1
Authority
DE
Germany
Prior art keywords
variant
mast
mitf
fusion protein
mast cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222265T
Other languages
English (en)
Other versions
DE60222265T2 (de
Inventor
Koji Naito
Shusei Uno
Eiji Asakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of DE60222265D1 publication Critical patent/DE60222265D1/de
Publication of DE60222265T2 publication Critical patent/DE60222265T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Coils Or Transformers For Communication (AREA)
  • Soft Magnetic Materials (AREA)
DE60222265T 2001-07-05 2002-07-04 Zelltod-induktoren für mastzellen Expired - Lifetime DE60222265T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001204567A JP2003009883A (ja) 2001-07-05 2001-07-05 マスト細胞の細胞死誘発剤
JP2001204567 2001-07-05
PCT/JP2002/006790 WO2003004047A1 (fr) 2001-07-05 2002-07-04 Inducteurs de mort cellulaire pour des mastocytes

Publications (2)

Publication Number Publication Date
DE60222265D1 true DE60222265D1 (de) 2007-10-18
DE60222265T2 DE60222265T2 (de) 2008-06-19

Family

ID=19041009

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222265T Expired - Lifetime DE60222265T2 (de) 2001-07-05 2002-07-04 Zelltod-induktoren für mastzellen

Country Status (6)

Country Link
US (1) US7217539B2 (de)
EP (1) EP1410802B1 (de)
JP (1) JP2003009883A (de)
AT (1) ATE372347T1 (de)
DE (1) DE60222265T2 (de)
WO (1) WO2003004047A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100685345B1 (ko) 2004-03-27 2007-02-22 학교법인조선대학교 세포사 유도 펩타이드
WO2005117928A1 (en) * 2004-05-30 2005-12-15 Cemines, Inc. Compositions and methods for the treatment of skin cancer
CN101016340A (zh) * 2007-01-18 2007-08-15 夏献民 融合多肽及其在肿瘤与细胞生长异常相关的疾病治疗中的用途
CA2936675C (en) 2014-01-12 2023-06-27 Igf Oncology, Llc Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
KR102619496B1 (ko) 2016-07-19 2023-12-29 유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 Stat3를 타겟으로 하는 종양용해성 바이러스
AU2018273370A1 (en) 2017-05-21 2019-10-31 Igf Oncology, Llc An insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome
CA3215344A1 (en) 2021-04-30 2022-11-03 Kalivir Immunotherapeutics, Inc. Oncolytic viruses for modified mhc expression
PL244930B1 (pl) 2021-12-08 2024-04-02 Gdanski Univ Medyczny Zastosowanie 2-metoksyestradiolu w leczeniu mastocytozy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505102A (ja) * 1989-12-21 1993-08-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 真核細胞の中に分子を配達する方法
EP1005486A4 (de) * 1997-08-22 2004-09-29 Univ Washington Induzierbare regulatorische systeme und deren verwendung
GB9902776D0 (en) * 1999-02-08 1999-03-31 Marie Curie Cancer Care Materials and methods relating to a cancer cell marker
WO2001066735A1 (fr) 2000-03-08 2001-09-13 Mitsubishi Pharma Corporation Protéines associées au mitf

Also Published As

Publication number Publication date
JP2003009883A (ja) 2003-01-14
EP1410802B1 (de) 2007-09-05
US7217539B2 (en) 2007-05-15
EP1410802A1 (de) 2004-04-21
EP1410802A4 (de) 2005-04-13
US20040248787A1 (en) 2004-12-09
ATE372347T1 (de) 2007-09-15
DE60222265T2 (de) 2008-06-19
WO2003004047A1 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
CY1117672T1 (el) Αναστολεις της ανθρωπινης δελτα φωσφατιδυλ-ινοσιτολ-3-κινασης
WO2006009809A3 (en) Vegf inhibitors for the treatment of malignant pleural effusion
Capuano et al. Oxidative phosphorylation enzymes in normal and neoplastic cell growth
MXPA04005880A (es) Cis-imidazolinas como inhibidores de la mdm2.
MY128441A (en) Bipiperidine derivatives as modulators of ccr3 activity and as h1 antogonists
HK1041521A1 (en) Growth differentiation factor inhibitors and uses therefor
MY139689A (en) Imidazotriazines as protein kinase inhibitors
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
DK0773955T3 (da) Hidtil ukendte inhibitorer for thrombin, deres fremstilling og anvendelse
ATE217865T1 (de) Verbindungen zur hemmung von phosphodiesrerase iv
MY120064A (en) Indole derivatives as inhibitors or factor xa
DE60222265D1 (de) Zelltod-induktoren für mastzellen
PT1307455E (pt) Inibidores de adesao celular mediada por (alfa)l (beta)2
DE60040397D1 (de) Substituierte alpha-hydroxy-säuren als caspase-hemmer und ihre verwendung
ATE369860T1 (de) Verwendung von pdgf-rezeptor tyrosin kinase inhibitoren zur behandlung von diabetischer nephropathie
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
SG11201901619WA (en) Bicyclic nitrogenated heterocyclic compound
NO983992L (no) Serinprotease inhibitorer
MD1688F2 (en) Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection
MXPA04006255A (es) Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
ATE429916T1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
ES2125004T3 (es) Derivados peptidicos de trifluorometilcetona puros, diastereoisomeros, como inhibidores de leucocitoelastasa humana.
MX9701776A (es) Uso de factores de crecimiento similares a insulina i y ii para la inhibicion de la respuesta inflamatoria.
DE602004029173D1 (de) Il-21-derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition